These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38751338)

  • 1. Toward microfluidic continuous-flow and intelligent downstream processing of biopharmaceuticals.
    Sharma V; Mottafegh A; Joo JU; Kang JH; Wang L; Kim DP
    Lab Chip; 2024 May; 24(11):2861-2882. PubMed ID: 38751338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidic platform for rapid screening of bacterial cell lysis.
    Fradique R; Azevedo AM; Chu V; Conde JP; Aires-Barros MR
    J Chromatogr A; 2020 Jan; 1610():460539. PubMed ID: 31543341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensors and chemometrics in downstream processing.
    Dürauer A; Jungbauer A; Scharl T
    Biotechnol Bioeng; 2024 Aug; 121(8):2347-2364. PubMed ID: 37470278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward Personalized Cancer Treatment: From Diagnostics to Therapy Monitoring in Miniaturized Electrohydrodynamic Systems.
    Khondakar KR; Dey S; Wuethrich A; Sina AA; Trau M
    Acc Chem Res; 2019 Aug; 52(8):2113-2123. PubMed ID: 31293158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of host cell proteins in the downstream process of plant-Based biologics using LC-MS profiling.
    Panapitakkul C; Bulaon CJI; Pisuttinusart N; Phoolcharoen W
    Biotechnol Rep (Amst); 2024 Dec; 44():e00856. PubMed ID: 39376902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions.
    Szkodny AC; Lee KH
    Annu Rev Chem Biomol Eng; 2022 Jun; 13():141-165. PubMed ID: 35300518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic Devices as Process Development Tools for Cellular Therapy Manufacturing.
    Aranda Hernandez J; Heuer C; Bahnemann J; Szita N
    Adv Biochem Eng Biotechnol; 2022; 179():101-127. PubMed ID: 34410457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous integrated manufacturing for biopharmaceuticals: A new paradigm or an empty promise?
    Rathore AS; Thakur G; Kateja N
    Biotechnol Bioeng; 2023 Feb; 120(2):333-351. PubMed ID: 36111450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments and opportunities in continuous biopharmaceutical manufacturing.
    Khanal O; Lenhoff AM
    MAbs; 2021; 13(1):1903664. PubMed ID: 33843449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time detection of mAb aggregates in an integrated downstream process.
    São Pedro MN; Isaksson M; Gomis-Fons J; Eppink MHM; Nilsson B; Ottens M
    Biotechnol Bioeng; 2023 Oct; 120(10):2989-3000. PubMed ID: 37309984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expediting online liquid chromatography for real-time monitoring of product attributes to advance process analytical technology in downstream processing of biopharmaceuticals.
    Graf T; Naumann L; Bonnington L; Heckel J; Spensberger B; Klein S; Brey C; Nachtigall R; Mroz M; Hogg TV; McHardy C; Martinez A; Braaz R; Leiss M
    J Chromatogr A; 2024 Aug; 1729():465013. PubMed ID: 38824753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects of Microfluidic Technology in Nucleic Acid Detection Approaches.
    Mumtaz Z; Rashid Z; Ali A; Arif A; Ameen F; AlTami MS; Yousaf MZ
    Biosensors (Basel); 2023 May; 13(6):. PubMed ID: 37366949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluidic-integrated DNA nanobiosensors.
    Ansari MIH; Hassan S; Qurashi A; Khanday FA
    Biosens Bioelectron; 2016 Nov; 85():247-260. PubMed ID: 27179566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current challenges in biotherapeutic particles manufacturing.
    Moleirinho MG; Silva RJS; Alves PM; Carrondo MJT; Peixoto C
    Expert Opin Biol Ther; 2020 May; 20(5):451-465. PubMed ID: 31773998
    [No Abstract]   [Full Text] [Related]  

  • 15. Fully integrated downstream process to enable next-generation manufacturing.
    Ramos I; Sharda N; Villafana R; Hill-Byrne K; Cai K; Pezzini J; Coffman J
    Biotechnol Bioeng; 2023 Jul; 120(7):1869-1881. PubMed ID: 36950907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing.
    Fisher AC; Kamga MH; Agarabi C; Brorson K; Lee SL; Yoon S
    Trends Biotechnol; 2019 Mar; 37(3):253-267. PubMed ID: 30241924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for Enhancing Quality and Capability of Indian Biopharmaceutical Industry: Summary of a Workshop.
    Uppal A; Koduri CK; Yadlapalli S; Chirmule N; Chakrabarti R; Atouf F
    J Pharm Sci; 2020 Oct; 109(10):2958-2961. PubMed ID: 32710904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionic-liquid-based approaches to improve biopharmaceuticals downstream processing and formulation.
    Almeida C; Pedro AQ; Tavares APM; Neves MC; Freire MG
    Front Bioeng Biotechnol; 2023; 11():1037436. PubMed ID: 36824351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.